Latest SenzaGen News & Updates

See the latest news and media coverage for SenzaGen. We track all announcements, press releases, and industry mentions in real time, all in one place.

SenzaGen

In vitro testing laboratory for chemical and medical device safety

senzagen.com

Headquarters: Lund, Sweden
Founded year: 2010
Company type: Public company
Number of employees: 20–50

Last updated Today

Latest news about SenzaGen

In short: SenzaGen expanded its market presence through strategic orders, record GARD sales, and increased regulatory alignment for its non-animal testing.

Company announcements

June 5 SenzaGen

SenzaGen says EU roadmap boosts its long-term market potential

The European Commission's plan prioritizes sensitization testing fully by 2029, increasing demand for SenzaGen's GARD tests.

May 12 SenzaGen

SenzaGen reports 10% sales growth in Q1 2026 interim report

Net sales rose to SEK 15.0 million, with EBIT improving slightly. The company highlights increased attention to non-animal methods.

April 21 SenzaGen

SenzaGen publishes its 2025 Annual Report

A digital copy is available for download at www.senzagen.com. Printed copies can be requested via IR@senzagen.com.

April 8 SenzaGen

SenzaGen issues notice of annual general meeting

The AGM is scheduled for 12 May 2026 at 2 PM in Lund, Sweden. It includes approval of financial statements, board elections, remuneration policies, and share issuance authorization.

Media coverage

June 9 FinanzNachrichten

SenzaGen AB: SenzaGen's subsidiary receives two orders within non-animal testing with a total value of SEK 2.4 million

SenzaGen's subsidiary VitroScreen has received two orders from existing customers for non-animal testing. The total order value amounts to SEK 2.4 million, with the majority...

May 12 FinanzNachrichten

SenzaGen AB: SenzaGen's interim report January-March 2026 | 10% sales growth alongside increased attention to non-animal methods

"We started the year with 10 percent growth despite negative foreign exchange effects and the impact of a subsidiary undergoing a transition. At the same...

April 15 FinanzNachrichten

SenzaGen AB: SenzaGen's subsidiary receives strategically important order

SenzaGens's subsidiary VitroScreen has received an order from an existing customer for non-animal efficacy testing. The order includes studies using the proprietary platform VitroScreenORA® and...

March 30 MarketWatch

SenzaGen AB

SenzaGen AB Annual cash flow by MarketWatch. View 26S net cash flow, operating cash flow, operating expenses and cash dividends.

Never miss news about SenzaGen

Track SenzaGen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

SenzaGen competitors & trending companies

Browse news for competitors to SenzaGen and other trending companies.